Compared with PBS-treated group (control group) and CRO-treated group (aptamer control group), the others groups exhibited significantly lower tumor volumes, wherein the NucA-PTX treated group showed a better inhibitory effect against tumor growth that PTX-treated group or nucleolin aptamer-treated group (Fig. 7a). Here, NUCLEOLIN is linked to neoplasm.